Proteinase inhibitors research monographs in cell and tissue physiology, vol. 12  Edited by A.J. Barrett and G. Salvesen Elsevier; Amsterdam, 1986 660 pages. $160.00, Dfl.400.00 by Kay, John
Volume 226. number 1 FEBS LETTERS December 1987 
Proteinase Inhibitors 
Research Monographs in Cell and Tissue Physiology, Vol. 12 
Edited by A.J. Barrett and G. Salvesen 
Elsevier; Amsterdam, 1986 
660 pages. $160.00, Df1.400.00 
Twenty-one chapters from individual authors are 
combined together in this volume under the 
editorial direction of Alan Barrett and Guy 
Salvesen. Previously, Dr Barrett has produced a 
number of treatises on the topic of proteolytic en- 
zymes and one suspects that these have now assum- 
ed ‘text-book’ status on most library shelves. It 
seems singularly appropriate and of considerable 
value, particularly with the current preoccupation 
with gene technology for the expression of recom- 
binant proteins in foreign cells, to release a com- 
panion volume which documents with an authority 
matching that in its predecessors, the variety and 
selectivity of inhibitors which regulate the pro- 
teolytic enzymes. 
All known proteinases may be classified on the 
basis of their catalytic mechanism into one of only 
four categories and the first of two preliminary 
chapters thus introduces the serine, cysteine, 
aspartic and metalloproteinases. It is accompanied 
by a valuable, well-written chapter reviewing 
kinetic procedures for the assessment of pro- 
teinase : anti-proteinase interactions. Four articles 
then ensue in which peptide inhibitors of the four 
classes of enzyme evolved by nature over 
thousands of years are considered in turn and 
evaluated against synthetic analogues devised and 
synthesised by man within a minute time frame. 
The successes of such strategies are most im- 
pressive. 
Ten chapters on individual proteins that are 
serine proteinase inhibitors (= serpins) reveal the 
massive amount of information that is now 
available on what has undoubtedly been the most 
frequently studied class of enzyme. In more recent 
years, the discovery of the cystatins, a superfamily 
of cysteine proteinase inhibitors, has made it possi- 
ble to have an informative chapter on this subject 
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which has not been previously described elsewhere. 
The non-conformist inhibitors of cysteine pro- 
teinases, the calpastatins, are sufficiently eccentric 
in their behaviour to warrant the treatment that 
they receive as a separate topic. The selectivity of 
these inhibitors is remarkable in that they have no 
effect whatsoever on any proteinase other than 
their specific target, the Ca2+-activated cysteine 
proteinases (or calpains). An even more unusual 
feature is the ability of one molecule of inhibitor to 
negate (considerably) more than one molecule of 
calpain; a fact that has recently been substantiated 
by the observation of repetition within the (gene) 
structure of the inhibitor. This leads on to con- 
sideration of protein inhibitors of metallopro- 
teinases including the tissue inhibitor of 
metalloproteinases (= TIMP) that is exported by a 
number of cells to regulate the degradation of the 
matrix of connective tissue. 
After the detailed scrutiny of all of these 
naturally-occurring protein inhibitors of serine, 
cysteine and metalloproteinases, the absence of a 
chapter on protein inhibitors of aspartic pro- 
teinases would seem at first glance to be a glaring 
oversight. Not so, however, in that very few such 
proteins actually exist. Nature appears to have 
evolved different mechanisms (pH; rate of supply 
of substrate) for the regulation of these enzymes by 
comparison with the other three classes. 
A final chapter focusses attention on the every- 
day significance of what has gone before in 
evaluating the importance of proteinase inhibitors 
as drugs. At just over &loo, this volume is on the 
expensive side but even so, just as with Jeffrey 
Archer, it would seem destined to become the 
latest in a series of best sellers. 
John Kay 
